（Last updated : 2025-05-06 16:41:06）
  幸地 優希
   Department   The Jikei University School of Medicine  , The Jikei University School of Medicine
   Position   Research Associate
■ Journal
1. 　 Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer. 2024/06
■ Academic background
1. 2013/04～2019/03 The Jikei University School of Medicine, Graduated
■ Presentation
1. Clinicopathological analysis of 1333 cases with epithelial ovarian cancer using real-world data at a tertiary center in Japan: a retrospective observational study （Speech，General） 2023/05/12
2. Effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese epithelial ovarian cancer: a single-center retrospective study （Poster notice，General） 2023/11/04
3. The utility of KELIM for predicting prognosis and indicating therapeutic selection among Japanese patients with high-grade serous ovarian carcinoma: a single-center retrospective observational study. （Poster notice，General） 2024/10/16